News

GlobalData on MSN19h
Isomorphic Labs prepares to launch trials for AI-designed drugs
Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...
The Express Tribune23h
Google-backed Isomorphic Labs to launch human trials for AI-designed drugs
Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...
Alphabet-Backed Drug Discovery Firm Nears Human Trials Of AI-Developed Remedies, Says President: 'The Next Big Milestone Is…'
Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...
Budget policy, digital euro, and banking union are top priorities, says Eurogroup President
Pascal Donohoe, President of the Eurogroup and Ireland's Minister of Finance, discusses his priorities for the Eurogroup in ...
Beauty by Rositax on MSN19h
Obsessed With This Fwee Blush
Julie Bowen Thought ‘Happy Gilmore 2' Would Replace Her With a ‘Younger Woman': ‘I Didn't Think They'd Bring Me Back at All' ...
Technowize18h
Alphabet’s Isomorphic Labs Gets Set for Human Trials of AI-Designed Drugs
Out to make a bigger difference, Alphabet’s Isomorphic Labs is exploring a much more useful application of AI. The Google ...
A Once-in-a-Decade Opportunity: Alphabet's Stock Looks Like a Brilliant Buy Right Now
Investors are worried about Google's falling market share. The Google Search engine saw its revenue rise 10% in Q1. Alphabet ...